Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
+744K
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
+$22.9M
-
Put/Call ratio
-
3.74
-
Number of buys
-
85
-
Number of sells
-
-88
-
Price
-
$29.39
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q2 2020
249 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q2 2020.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
.
Largest 10 shareholders include BlackRock Inc. (5.35M shares), VANGUARD GROUP INC (4.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.05M shares), Champlain Investment Partners, LLC (3.35M shares), WELLINGTON MANAGEMENT GROUP LLP (3.29M shares), Paradice Investment Management LLC (2.65M shares), DIMENSIONAL FUND ADVISORS LP (2.18M shares), VICTORY CAPITAL MANAGEMENT INC (1.95M shares), STATE STREET CORP (1.79M shares), and MACQUARIE GROUP LTD (1.67M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.